CDK4 and neutropenia: Neutropenia associated with CDK4/6 inhibitors is different from chemotherapy-induced neutropenia in that it is rapidly reversible due to a cytostatic (as opposed to cytotoxic) effect on neutrophil precursors in the bone marrow.